PEDF is an endogenous angiogenic inhibitor in the eye and can counterbalance the angiogenic effect of VEGF and suppress neovascularization in PDR and age-related macular degeneration (AMD) [24–27]. The gene discussed is VEGFA; the disease is age-related macular degeneration.